Annatto-derived GG for Statin-associated Myopathy

Description

To evaluate the effects of 3-months annatto-derived geranylgeraniol (GG) supplementation on statin-associated skeletal muscle health.

Conditions

Myopathy; Primary

Talk to us

Study Overview

On this page

Study Details

Study overview

To evaluate the effects of 3-months annatto-derived geranylgeraniol (GG) supplementation on statin-associated skeletal muscle health.

Effect of Annatto-derived Geranylgeraniol (GG) on Statin-associated Myopathy

Annatto-derived GG for Statin-associated Myopathy

Condition
Myopathy; Primary
Intervention / Treatment

-

Contacts and Locations

Lubbock

Texas Tech University Health Sciences Center, Lubbock, Texas, United States, 79430

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥40 of either sex
  • * Statin-treated patients with muscle pain alone or accompanied by other symptoms.
  • * Patients currently receiving a statin who developed new-onset myalgias in within 90 day of initiation or a dosage increase
  • * Malignancy or significant neurological or psychiatric disturbances, including alcohol or drug abuse.
  • * Woman who is pregnant, breastfeeding, or of childbearing potential and not taking adequate contraceptive precautions.
  • * Had CoQ10 supplement one month before starting the study.
  • * Genetic musculoskeletal and neurologic disorder known to affect skeletal muscle metabolism
  • * Had steroid medication one month before starting the study.

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Texas Tech University Health Sciences Center,

Chwan-Li (Leslie) Shen, PhD, PRINCIPAL_INVESTIGATOR, Texas Tech Health Science Center

Study Record Dates

2025-12-31